Representatives of regulatory authorities, the pharmaceutical industry and the World Health Organization have agreed to put in place a structured process to align global recommendations on the composition of updated COVID-19 vaccines and to optimize their regulatory approval.
The agreement was reached at a 26-27 February virtual workshop attended by more than 35 drug regulators as well as scientific experts from the WHO, the European Commission and industry, and organized jointly by the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?